Monday Volume 505 8 February 2010 No. 39 HOUSE OF COMMONS OFFICIAL REPORT PARLIAMENTARY DEBATES (HANSARD) Monday 8 February 2010 £5·00 © Parliamentary Copyright House of Commons 2010 This publication may be reproduced under the terms of the Parliamentary Click-Use Licence, available online through the Office of Public Sector Information website at www.opsi.gov.uk/click-use/ Enquiries to the Office of Public Sector Information, Kew, Richmond, Surrey TW9 4DU; e-mail:
[email protected] 603 8 FEBRUARY 2010 604 Alan Johnson: Yes, I spoke to Professor Les Iversen, House of Commons the new chair of the ACMD, last week. This is a priority for the council—an absolute priority. It expects to receive Monday 8 February 2010 the advice on 22 February. Thereafter, it expects to make a decision in early March. It is a priority and the council is moving as quickly as it can, consistent—this The House met at half-past Two o’clock is the point I made earlier—with trying to ensure that it deals not only with mephedrone, but the whole generic group, so we will not be fooled by the manufacturers’ PRAYERS shifting around. [MR.SPEAKER in the Chair] Dr. Brian Iddon (Bolton, South-East) (Lab): As we consider substances in the cathinone group of chemicals— that includes khat, by the way, which is used by people from the horn of Africa—is there not a danger that, as Oral Answers to Questions we put more and more substances into the ABC classification, we merely displace the problem? There is an endless list of chemicals and natural products that chemists can supply on to the market.